Colin A. McCannel, M.D.
Colin A. McCannel, M.D., F.A.C.S., F.R.C.S.C., is professor of clinical ophthalmology at the Jules Stein Eye Institute, University of California, Los Angeles, and medical director of UCLA’s Stein Eye Center–Santa Monica.
Dr. McCannel specializes in retinal surgery. He received his medical degree from the Mayo Medical School in Rochester, Minnesota. He is a member of the American Society of Retina Surgeons, the Retina Society, the Macula Society, the American Academy of Ophthalmology, California Academy of Eye Physicians and Surgeons, and the American Medical Association. In the past he was a member of the Minnesota Academy of Ophthalmology, where he was also a member of the board of directors and past president.
Dr. McCannel’s clinical interests include surgical and medical diseases of the retina, macula and vitreous, including diabetic retinopathy, macular hole, retinal detachment, complex retinal detachment, epimacular membrane (epiretinal membrane, macular pucker), and age-related macular degeneration. He has lectured worldwide and is a reviewer for several prestigious journals, including the Archives of Ophthalmology, Ophthalmology, and the American Journal of Ophthalmology. He is also a leader in the field of the use of virtual reality simulation technology for ophthalmic surgical teaching.
Latest by Colin A. McCannel, M.D.
Research on a bionic eye is underway, which could conceivably offer hope for improved vision in people with dry AMD.
Depression is common in people with age-related macular degeneration—the leading cause of vision loss in older adults. Here’s what to know.
Because untreated glaucoma can cause permanent blindness, research is a major priority. Here’s what’s on the horizon.
People who eat green leafy vegetables like kale have a lower risk for primary open-angle glaucoma and early central vision loss, a study has found.
This study comparing three medications for diabetic macular edema showed that all three produced significant vision improvements after two years.
As people age, problems with vision, such as cataracts, and mental functioning often occur together. Might correcting one improve the other?
Stimulation from electrical alternating current may partially restore vision in glaucoma patients who still have some residual vision.
After five years of drug treatment, about half of people with wet age-related macular degeneration had vision good enough to drive or to read standard print.
Age-related macular degeneration and cardiovascular disease share multiple risk factors, which suggests that therapies that work for one may benefit the other.